Clinical Trials Logo

Filter by:
NCT ID: NCT00565838 Completed - Clinical trials for Stress Urinary Incontinence

Quality-of-Life Outcomes After Autologous Fascial Sling and TVT: a Prospective Randomized Trial

Start date: January 2001
Phase: N/A
Study type: Observational

The objective of the study was to evaluate the impact AFS and TVT procedures on quality-of-life in incontinent women.

NCT ID: NCT00565448 Completed - Carcinoma Clinical Trials

Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and Adolescents

Start date: November 2007
Phase: Phase 2
Study type: Interventional

The primary objective is to estimate the Complete Response rate of docetaxel to the combination of cisplatin-5-fluorouracil (TCF) compared to cisplatin-5-fluorouracil (CF) in the Induction treatment of Nasopharyngeal Carcinoma (NPC). The secondary objectives are to determine: - the safety of TCF in comparison to CF after induction treatment of NPC, - the pharmacokinetics of docetaxel when added to CF, - the Overall Response rate of TCF and CF on completion of induction and consolidation (chemo-radiotherapy) treatment of NPC, and to compare overall survival between TCF and CF.

NCT ID: NCT00564811 Completed - Hepatitis C Clinical Trials

Effect of Agaricus Blazei (Murrill) ss. Heinemann (Sun Mushroom)

Start date: March 2003
Phase: N/A
Study type: Interventional

The aim of the study was to verify the influence of Agaricus blazei (Murrill) ss. Heinemann (A. blazei) on the evolution of nutritional state and liver function in hepatitis C patients.

NCT ID: NCT00564564 Completed - Clinical trials for Obsessive Compulsive Disorder

Quetiapine Augmentation Versus Clomipramine Augmentation of SSRI for Obsessive-compulsive Disorder Patients

QCAT
Start date: January 2006
Phase: Phase 4
Study type: Interventional

The objective of this trial is to compare in an open trial format the efficacy of association of clomipramine and quetiapine with SSRI after SSRI treatment failed to produce complete remission of obsessive compulsive disorder symptoms.

NCT ID: NCT00561470 Completed - Clinical trials for Colorectal Neoplasms

Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen

VELOUR
Start date: November 2007
Phase: Phase 3
Study type: Interventional

The main objective of the study was to evaluate the effectiveness of aflibercept (versus placebo) in increasing the overall survival in participants with metastatic colorectal cancer treated with FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) and that have previously failed an oxaliplatin based treatment for metastatic disease. The secondary objectives were to compare progression-free survival, to evaluate overall response rate, to evaluate the safety profile, to assess immunogenicity of intravenous (IV) aflibercept, and to assess pharmacokinetics of IV aflibercept in both treatment arms.

NCT ID: NCT00560521 Completed - Tuberculosis Clinical Trials

Continuous Positive Airway Pressure on Tuberculosis Pleural Effusion

Start date: March 2005
Phase: N/A
Study type: Interventional

Tuberculosis (TB) remains as an important public health problem worldwide. Pleural tuberculosis is the most prevalent form of extrapulmonary presentation in immunocompetent patients. The volume of effusion in the pleural space of patients with pleural TB may cause complications like restrictive ventilator lung functional disturb and/or pleural thickening. The respiratory physiotherapy can be adjuvant on treatment of pleural effusion tuberculosis throughout of various treatment technique. The Continuous positive airway pressure (CPAP) is utilized in various pathologic, this improves lung mechanics by recruiting atelectatic alveoli, improving pulmonary compliance, and reducing the work of breathing. The aim of this study is to determine the effect of CPAP on fluid absorption among patients with pleural effusion due tuberculosis.

NCT ID: NCT00560404 Completed - Anemia Clinical Trials

A Study of Subcutaneous Mircera for the Maintenance Treatment of Dialysis Patients With Chronic Renal Anemia.

Start date: n/a
Phase: Phase 3
Study type: Interventional

This 2 arm study will compare the efficacy and safety of monthly administration of subcutaneous Mircera versus epoetin alfa for the maintenance of hemoglobin levels in dialysis patients with chronic renal anemia. Patients currently receiving maintenance treatment with epoetin alfa will be randomized to receive either monthly injections of Mircera with a starting dose (120, 200 or 360 micrograms) derived from the dose of epoetin alfa they were receiving in the week preceding study start, or to continue on epoetin alfa treatment. The anticipated time on study treatment is 3-12 months, and the target sample size is 100-500 individuals.

NCT ID: NCT00560235 Completed - Clinical trials for Ewing's Sarcoma Family of Tumors

Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors

Start date: March 2008
Phase: Phase 1/Phase 2
Study type: Interventional

Define the efficacy of CP-751,871 in patients with Ewing's sarcoma family of tumors

NCT ID: NCT00560079 Completed - Mania Clinical Trials

Efficacy of Allopurinol and Dypiridamole in Acute Mania

Start date: November 2003
Phase: Phase 4
Study type: Interventional

This study aims to evaluate the potential antimanic efficacy, safety and tolorability of the purinergic agents allopurinol and dipyridamole as an add-on treatment to lithium in a sample of 180 drug-free manic patients enrolled in a double-blind, placebo-controlled design.

NCT ID: NCT00559585 Completed - Clinical trials for Rheumatoid Arthritis (RA)

Methotrexate-Inadequate Response Study

Start date: January 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether a weekly subcutaneous dose of abatacept yields clinical efficacy comparable to that of monthly intravenous doses of abatacept in participants with rheumatoid arthritis and an inadequate response to current methotrexate therapy.